<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03832439</url>
  </required_header>
  <id_info>
    <org_study_id>16-003300</org_study_id>
    <nct_id>NCT03832439</nct_id>
  </id_info>
  <brief_title>Probiotic Supplementation on Weight Loss</brief_title>
  <official_title>The Effect of Probiotic Supplementation on Weight Loss, and Its Association With the Gut Microbiome After Bariatric Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are trying to better understand how bariatric surgery leads to weight loss,&#xD;
      and the role of bacteria that live in the gut in making this happen.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are interested in seeing how a probiotic, which is a dietary supplement&#xD;
      containing large amounts of 'good' bacteria, can influence the make-up of the gut bacterial&#xD;
      population and what effect it has on weight loss and loss of fat. Before undergoing weight&#xD;
      loss surgery (sleeve gastrectomy or roux-en-y gastric bypass), study participants will be&#xD;
      asked to provide a stool sample to assess the make-up of their gut bacterial population. They&#xD;
      will also undergo a limited CT scan of the abdomen and DEXA (Xray) to help assess the amount&#xD;
      of fat present inside the body.&#xD;
&#xD;
      After undergoing weight loss surgery (sleeve gastrectomy or roux-en-y gastric bypass), study&#xD;
      participants will be given either a probiotic supplement or dummy pill (placebo) for 3&#xD;
      months, in addition to all usual care that occurs after surgery. The CT scan, DEXA scan and&#xD;
      stool sample will be repeated at the end of the 3 month period and analyzed for changes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>3 months</time_frame>
    <description>Change in body weight from baseline to 3 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visceral fat loss</measure>
    <time_frame>3 months</time_frame>
    <description>Change in visceral fat from baseline to 3 months</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will be receiving probiotic supplements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This arm will be receiving placebo containing microcrystalline cellulose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>Lactobacillus rhamnosus GG 10 billion cells and microcrystalline cellulose</description>
    <arm_group_label>Probiotic</arm_group_label>
    <other_name>CulturelleÂ®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>microcrystalline cellulose</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. All subjects who are &gt; 18 and &lt; 65 years of age recruited from the Mayo Clinic&#xD;
             bariatric surgery clinic&#xD;
&#xD;
          2. Will also meet one of the National Institute of Health's criteria for bariatric&#xD;
             surgery, i.e. body mass index (BMI) &gt; 40 kg/m2 or BMI &gt; 35 kg/m2 with significant&#xD;
             weight-related comorbidities.&#xD;
&#xD;
          3. Patients will be eligible if they are not on chronic antibiotic therapy and without&#xD;
             active systemic illness.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with type 1 or 2 diabetes will be excluded due to the known pre-existing&#xD;
             changes in the gut microbiome in this population. All patients will not have had&#xD;
             exposure to probiotics, prebiotics or antibiotics in the preceding 4 weeks.&#xD;
&#xD;
          2. Patients with allergy to antibiotics precluding the use of standard peri-operative&#xD;
             antibiotics (cefazolin and metronidazole) will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meera Shah, M.B., Ch.B</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vishakantha Murthy, PhD</last_name>
    <phone>507-255-8112</phone>
    <email>Murthy.Vishakantha@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vishakantha Murthy, PhD</last_name>
      <phone>507-255-8112</phone>
      <email>Murthy.Vishakantha@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Meera Shah, M.B., Ch.B</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 4, 2019</study_first_submitted>
  <study_first_submitted_qc>February 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2019</study_first_posted>
  <last_update_submitted>February 11, 2021</last_update_submitted>
  <last_update_submitted_qc>February 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Meera Shah, M.B., Ch.B.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Probiotic</keyword>
  <keyword>Microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

